Overview
Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to investigate the pharmacokinetic (PK) properties of various modified release tablet formulations of Lu AF11167 (Part A) and to investigate the pharmacokinetic (PK) properties of a modified release tablet formulation of Lu AF11167 in a fed and fasted state and following multiple dosing (Part B).Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
H. Lundbeck A/S
Criteria
Inclusion Criteria:- Healthy men and women ≥18 and ≤45 years of age with a body mass index (BMI) of >18.5
and <30.0 kg/m2.
- Women of child-bearing potential will have a confirmed non-pregnant and non-lactating
status.
- Other pre-defined inclusion and exclusion criteria may apply.